Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 70326 - 70350 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	ECEL1	9427	downregulated	Silicon Dioxide analog results in decreased expression of ECEL1 mRNA	2q37.1	A24195
Silicon dioxide	Approved	ECM1	1893	upregulated	Silicon Dioxide analog results in increased expression of ECM1 mRNA	1q21.2	A24195
Silicon dioxide	Approved	ECM2	1842	upregulated	Silicon Dioxide analog results in increased expression of ECM2 mRNA	9q22.31	A24195
Silicon dioxide	Approved	ECT2	1894	upregulated	Silicon Dioxide results in increased expression of ECT2 mRNA	3q26.31	A24196
Silicon dioxide	Approved	EDAR	10913	downregulated	Silicon Dioxide analog results in decreased expression of EDAR mRNA	2q13	A24195
Silicon dioxide	Approved	EDAR	10913	downregulated	Silicon Dioxide results in decreased expression of EDAR mRNA	2q13	A24196
Silicon dioxide	Approved	EDN1	1906	downregulated	Silicon Dioxide analog results in decreased expression of EDN1 mRNA	6p24.1	A24195
Silicon dioxide	Approved	EDN1	1906	upregulated	Silicon Dioxide results in increased expression of EDN1 mRNA	6p24.1	A24196
Silicon dioxide	Approved	EDN3	1908	downregulated	Silicon Dioxide analog results in decreased expression of EDN3 mRNA	20q13.32	A24195
Silicon dioxide	Approved	EDNRA	1909	downregulated	Silicon Dioxide analog results in decreased expression of EDNRA mRNA	4q31.22-q31.23	A24195
Silicon dioxide	Approved	EDNRA	1909	downregulated	Silicon Dioxide results in decreased expression of EDNRA mRNA	4q31.22-q31.23	A24196
Silicon dioxide	Approved	EEF2KMT	196483	upregulated	Silicon Dioxide analog results in increased expression of EEF2KMT mRNA	16p13.3	A24195
Silicon dioxide	Approved	EEPD1	80820	upregulated	Silicon Dioxide analog results in increased expression of EEPD1 mRNA	7p14.2	A24195
Silicon dioxide	Approved	EFCAB11	90141	downregulated	Silicon Dioxide analog results in decreased expression of EFCAB11 mRNA	14q32.11	A24195
Silicon dioxide	Approved	EFCAB6	64800	downregulated	Silicon Dioxide analog results in decreased expression of EFCAB6 mRNA	22q13.2-q13.31	A24195
Silicon dioxide	Approved	EFEMP1	2202	upregulated	Silicon Dioxide analog results in increased expression of EFEMP1 mRNA	2p16.1	A24195
Silicon dioxide	Approved	EFHC1	114327	downregulated	Silicon Dioxide results in decreased expression of EFHC1 mRNA	6p12.2	A24196
Silicon dioxide	Approved	EFHD1	80303	downregulated	Silicon Dioxide analog results in decreased expression of EFHD1 mRNA	2q37.1	A24195
Silicon dioxide	Approved	EFHD2	79180	upregulated	Silicon Dioxide analog results in increased expression of EFHD2 mRNA	1p36.21	A24195
Silicon dioxide	Approved	EFNA1	1942	downregulated	Silicon Dioxide analog results in decreased expression of EFNA1 mRNA	1q22	A24195
Silicon dioxide	Approved	EFNA3	1944	upregulated	Silicon Dioxide analog results in increased expression of EFNA3 mRNA	1q21.3	A24195
Silicon dioxide	Approved	EFNB2	1948	upregulated	Silicon Dioxide analog results in increased expression of EFNB2 mRNA	13q33.3	A24194 A24195
Silicon dioxide	Approved	EFNB2	1948	upregulated	Silicon Dioxide results in increased expression of EFNB2 mRNA	13q33.3	A24196
Silicon dioxide	Approved	EFNB3	1949	downregulated	Silicon Dioxide analog results in decreased expression of EFNB3 mRNA	17p13.1	A24195
Silicon dioxide	Approved	EFR3B	22979	upregulated	Silicon Dioxide analog results in increased expression of EFR3B mRNA	2p23.3	A24195

Displaying entries 70326 - 70350 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability